Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000721748-13-000556
Filing Date
2013-08-23
Accepted
2013-08-22 19:21:29
Documents
10
Period of Report
2012-08-31

Document Format Files

Seq Description Document Type Size
1 gbiq083112finq.htm 10-Q 129842
2 gbiq311.htm EX-31.1 6301
3 gbiq312.htm EX-31.2 6636
4 CERTIFICATIONS PURSUANT TO 18 U.S.C. SECTIONS 1350 AS ADOPTED PURSUANT TO SECTIO gbiq321.htm EX-32.1 3153
  Complete submission text file 0000721748-13-000556.txt   1284549

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE gbiq-20120831.xml EX-101.INS 49285
6 XBRL SCHEMA FILE gbiq-20120831.xsd EX-101.SCH 10906
7 XBRL CALCULATION FILE gbiq-20120831_cal.xml EX-101.CAL 7338
8 XBRL DEFINITION FILE gbiq-20120831_def.xml EX-101.DEF 10345
9 XBRL LABEL FILE gbiq-20120831_lab.xml EX-101.LAB 79354
10 XBRL PRESENTATION FILE gbiq-20120831_pre.xml EX-101.PRE 61121
Mailing Address 2711 CENTERVILLE SUITE 400 WILMINGTON DE 19808
Business Address 2550 BATES RD. SUITE 212 MONTREAL A8 H3S 1A7 302 288 0658
Global Biotech Corp. (Filer) CIK: 0001126162 (see all company filings)

EIN.: 980229951 | Fiscal Year End: 0228
Type: 10-Q | Act: 34 | File No.: 000-33271 | Film No.: 131056108
SIC: 7389 Services-Business Services, NEC